Aids Air Ambulance Blood Plasma Trial Success
Pioneering products provided by Peli BioThermal, the global name in cold chain packaging, have proved critical in the success of an air ambulance blood plasma transportation trial.
Additional lives were saved thanks to the blood plasma products administered at accident scenes by the Great North Air Ambulance Service (GNAAS) which were safely transported in Peli BioThermal temperature controlled packaging products.
Peli BioThermal’s Crēdo ProMed™ is a robust, temperature controlled portable medical transport bag designed to ensure protected pharmaceutical products remain intact. The air ambulance crew used the thermal bags, which are utilised by emergency responders and medical couriers globally, throughout the recent trial.
The Crēdo ProMed™ transported the new blood plasma treatment during the five-month trial, which has now been extended so the service’s helicopters can carry defrosted fresh frozen plasma on board.
Paul Terry, Peli BioThermal’s Director of Sales EMEA, said: “We are delighted the trial has been so successful for this vital air ambulance service and Peli BioThermal products proved instrumental in ensuring the precious blood plasma, designated for emergency treatment, remained protected at all times.This trial success demonstrates how our robust and reliable temperature controlled packaging products are continually helping save lives here in the UK and worldwide.”
Paramedic, Andy Mawson, GNAAS deputy director of operations, said: “Transfusing blood products at the scene of an incident to a critically injured patient may save their life. We know that we can depend on the security and temperature of these products by using Peli BioThermal Crēdo ProMed™ transport bags which have never let us or our patients down.”
The trial by the GNAAS charity acknowledged a number of patients would have died without the new treatment and major trauma patients are alive today because of the rapid transfusions they received at the scene of their accident.
Plasma assists in stopping bleeding by helping blood clots to form. Previous to the introduction of plasma, patients would be stabilised using blood transfusions by the helicopter’s air doctor and then receive plasma on arrival at hospital.
Visit www.pelibiothermal.com to learn more about the wide range of Peli BioThermal products.
Peli BioThermal is a division of Peli Products, S.L.U., which is the European arm of Pelican Products, Inc., which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.
For further information please contact Amanda O’Hare on 01604 250900 or email email@example.com
About Peli Products
Peli Products, S.L.U. is the global leader in the design and manufacture of high-performance protective cases, temperature controlled packaging solutions, advanced portable lighting systems and rugged gear for professionals and outdoor enthusiasts. Headquartered in Torrance, CA, Pelican Products, Inc. operates in 21 countries, with 22 international sales offices and six manufacturing facilities across the globe. For more information, visit www.pelican.com or www.behrmancap.com.
About Peli BioThermal
Peli BioThermal Ltd. offers the widest range of temperature-controlled, thermally-protected packaging and service solutions to the global life sciences industry. The company’s products ensure that delicate biological materials arrive intact and effective, despite exterior environments. Peli BioThermal is dedicated to developing innovative products designed to fulfil the complex needs of the global life sciences industry. The company’s customers benefit from its extensive expertise in ensuring that temperature stability is maintained throughout the distribution chain. The company also offers a complete portfolio of services and software to support end-to-end temperature-controlled packaging asset management. Outside of Europe, the company does business under the name Pelican BioThermal LLC. For more information, visit www.pelibiothermal.com.
SOURCE: Pelican BioThermal